These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 20571936

  • 1. Angiogenesis and clinicopathologic characteristics in different hepatocellular carcinoma subtypes defined by EpCAM and α-fetoprotein expression status.
    Shan YF, Huang YL, Xie YK, Tan YH, Chen BC, Zhou MT, Shi HQ, Yu ZP, Song QT, Zhang QY.
    Med Oncol; 2011 Dec; 28(4):1012-6. PubMed ID: 20571936
    [Abstract] [Full Text] [Related]

  • 2. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
    Yamashita T, Forgues M, Wang W, Kim JW, Ye Q, Jia H, Budhu A, Zanetti KA, Chen Y, Qin LX, Tang ZY, Wang XW.
    Cancer Res; 2008 Mar 01; 68(5):1451-61. PubMed ID: 18316609
    [Abstract] [Full Text] [Related]

  • 3. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B, Cavard C, Perret C.
    J Hepatol; 2010 Feb 01; 52(2):280-1. PubMed ID: 20006402
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemical Coexpression of Epithelial Cell Adhesion Molecule and Alpha-Fetoprotein in Hepatocellular Carcinoma.
    Lima LDP, Machado CJ, Rodrigues JBSR, Vasconcellos LS, Junior EP, Vidigal PVT, Resende V.
    Can J Gastroenterol Hepatol; 2018 Feb 01; 2018():5970852. PubMed ID: 30112355
    [Abstract] [Full Text] [Related]

  • 5. Expression and role of epithelial cell adhesion molecule in dysplastic nodule and hepatocellular carcinoma.
    Bae JS, Noh SJ, Jang KY, Park HS, Chung MJ, Park CK, Moon WS.
    Int J Oncol; 2012 Dec 01; 41(6):2150-8. PubMed ID: 22993038
    [Abstract] [Full Text] [Related]

  • 6. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.
    Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E, Reid LM, Minato H, Honda M, Kaneko S, Tang ZY, Wang XW.
    Gastroenterology; 2009 Mar 01; 136(3):1012-24. PubMed ID: 19150350
    [Abstract] [Full Text] [Related]

  • 7. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma.
    Zeng SS, Yamashita T, Kondo M, Nio K, Hayashi T, Hara Y, Nomura Y, Yoshida M, Hayashi T, Oishi N, Ikeda H, Honda M, Kaneko S.
    J Hepatol; 2014 Jan 01; 60(1):127-34. PubMed ID: 24012616
    [Abstract] [Full Text] [Related]

  • 8. The Role of Epithelial Cell Adhesion Molecule Cancer Stem Cell Marker in Evaluation of Hepatocellular Carcinoma.
    El-Kholy MA, Abu-Seadah SS, Hasan A, Elhussiny MEA, Abdelwahed MS, Hanbazazh M, Samman A, Alrashdi SA, Rashed ZF, Ashmawy D, Othman AE, Abdelaleem MF, Abo-Saif AIA, Abdel-Maqsoud RR, Attiah SM, Assiri ES, Nasr M, Ismail KA, Saad DZ, El-Mosely MM.
    Medicina (Kaunas); 2024 May 30; 60(6):. PubMed ID: 38929532
    [Abstract] [Full Text] [Related]

  • 9. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF, Xu Y, Yang XR, Guo W, Zhang X, Qiu SJ, Shi RY, Hu B, Zhou J, Fan J.
    Hepatology; 2013 Apr 30; 57(4):1458-68. PubMed ID: 23175471
    [Abstract] [Full Text] [Related]

  • 10. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
    Wei Y, Wang Y, Gong J, Rao L, Wu Z, Nie T, Shi D, Zhang L.
    Int J Oncol; 2018 Jan 30; 52(1):219-230. PubMed ID: 29138811
    [Abstract] [Full Text] [Related]

  • 11. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma.
    Yamashita T, Honda M, Nakamoto Y, Baba M, Nio K, Hara Y, Zeng SS, Hayashi T, Kondo M, Takatori H, Yamashita T, Mizukoshi E, Ikeda H, Zen Y, Takamura H, Wang XW, Kaneko S.
    Hepatology; 2013 Apr 30; 57(4):1484-97. PubMed ID: 23174907
    [Abstract] [Full Text] [Related]

  • 12. Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+) AFP(+) hepatocellular carcinoma.
    Zhao X, Parpart S, Takai A, Roessler S, Budhu A, Yu Z, Blank M, Zhang YE, Jia HL, Ye QH, Qin LX, Tang ZY, Thorgeirsson SS, Wang XW.
    Oncogene; 2015 Sep 24; 34(39):5095-104. PubMed ID: 25597408
    [Abstract] [Full Text] [Related]

  • 13. High-level expression of HOXB13 is closely associated with tumor angiogenesis and poor prognosis of hepatocellular carcinoma.
    Zhu JY, Sun QK, Wang W, Jia WD.
    Int J Clin Exp Pathol; 2014 Sep 24; 7(6):2925-33. PubMed ID: 25031711
    [Abstract] [Full Text] [Related]

  • 14. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
    Schulze K, Gasch C, Staufer K, Nashan B, Lohse AW, Pantel K, Riethdorf S, Wege H.
    Int J Cancer; 2013 Nov 24; 133(9):2165-71. PubMed ID: 23616258
    [Abstract] [Full Text] [Related]

  • 15. Expression of epithelial cell adhesion molecule associated with elevated ductular reactions in hepatocellar carcinoma.
    Xu M, Qian G, Xie F, Shi C, Yan L, Yu L, Zheng T, Wei L, Yang J.
    Clin Res Hepatol Gastroenterol; 2014 Dec 24; 38(6):699-705. PubMed ID: 24924904
    [Abstract] [Full Text] [Related]

  • 16. The EpCAM overexpression is associated with clinicopathological significance and prognosis in hepatocellular carcinoma patients: A systematic review and meta-analysis.
    Zhou L, Zhu Y.
    Int J Surg; 2018 Aug 24; 56():274-280. PubMed ID: 29936198
    [Abstract] [Full Text] [Related]

  • 17. Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation.
    Zeng Z, Ren J, O'Neil M, Zhao J, Bridges B, Cox J, Abdulkarim B, Schmitt TM, Kumer SC, Weinman SA.
    BMC Cancer; 2012 Dec 07; 12():584. PubMed ID: 23216644
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients.
    Tseng PL, Tai MH, Huang CC, Wang CC, Lin JW, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Hu TH.
    J Surg Oncol; 2008 Oct 01; 98(5):349-57. PubMed ID: 18646041
    [Abstract] [Full Text] [Related]

  • 19. Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma.
    Guo Z, Li LQ, Jiang JH, Ou C, Zeng LX, Xiang BD.
    World J Gastroenterol; 2014 Feb 28; 20(8):2098-106. PubMed ID: 24616575
    [Abstract] [Full Text] [Related]

  • 20. A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer.
    Nam SJ, Yeo HY, Chang HJ, Kim BH, Hong EK, Park JW.
    Cancer Res Treat; 2016 Oct 28; 48(4):1229-1242. PubMed ID: 27034142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.